| Mr Deep Vinu Patel, MD | |
|
7605 Forest Ave, Suite 109, Richmond, VA 23229-4938 | |
| (804) 285-6390 | |
| (804) 285-6393 |
| Full Name | Mr Deep Vinu Patel |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 19 Years |
| Location | 7605 Forest Ave, Richmond, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154593168 | NPI | - | NPPES |
| VV3694B | Other | VA | MEDICARE PROVIDER PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 0101249866 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Westhampton Dialysis Center Llc | Richmond, VA | Dialysis facility |
| Us Renal Care - Warsaw | Warsaw, VA | Dialysis facility |
| Forest Park Dialysis Center | Richmond, VA | Dialysis facility |
| Henrico Doctors' Hospital | Richmond, VA | Hospital |
| Bon Secours St Marys Hospital | Richmond, VA | Hospital |
| Bon Secours Memorial Regional Medical Center | Mechanicsville, VA | Hospital |
| Bon Secours Richmond Community Hospital | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Specialists Pc | 4880676113 | 6 |
News Archive
Laser-emitting shoes and a Meccano-style walking aid kit are just two of the inventions being developed by companies in London and the south east that could help people stay independent for longer as they get older or develop debilitating illnesses, according to Design Council and MedCity, the Mayor of London's life sciences promotional organisation.
People who did not have a large heart rate response to a stress task surprised researchers later - after the onset of the COVID-19 pandemic - when they showed more symptoms of post-traumatic stress disorder related to the crisis than others who also did the stress task and COVID-19 stress ratings.
GAIN - the Global Alliance for Improved Nutrition released today its 2008-2009 Annual Report. The report confirms the effectiveness of GAIN's work in reducing malnutrition in high-burden countries.
Researchers at the University of Iowa Carver College of Medicine have discovered a genetic process that can restore function to a defective protein, which is the most common cause of cystic fibrosis (CF).
Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.
› Verified 1 days ago
| Entity Name | Nephrology Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578645107 PECOS PAC ID: 4880676113 Enrollment ID: O20040609000545 |
News Archive
Laser-emitting shoes and a Meccano-style walking aid kit are just two of the inventions being developed by companies in London and the south east that could help people stay independent for longer as they get older or develop debilitating illnesses, according to Design Council and MedCity, the Mayor of London's life sciences promotional organisation.
People who did not have a large heart rate response to a stress task surprised researchers later - after the onset of the COVID-19 pandemic - when they showed more symptoms of post-traumatic stress disorder related to the crisis than others who also did the stress task and COVID-19 stress ratings.
GAIN - the Global Alliance for Improved Nutrition released today its 2008-2009 Annual Report. The report confirms the effectiveness of GAIN's work in reducing malnutrition in high-burden countries.
Researchers at the University of Iowa Carver College of Medicine have discovered a genetic process that can restore function to a defective protein, which is the most common cause of cystic fibrosis (CF).
Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Deep Vinu Patel, MD 1603 Santa Rosa Rd, Rm 102, Richmond, VA 23229-5010 Ph: (804) 288-6750 | Mr Deep Vinu Patel, MD 7605 Forest Ave, Suite 109, Richmond, VA 23229-4938 Ph: (804) 285-6390 |
News Archive
Laser-emitting shoes and a Meccano-style walking aid kit are just two of the inventions being developed by companies in London and the south east that could help people stay independent for longer as they get older or develop debilitating illnesses, according to Design Council and MedCity, the Mayor of London's life sciences promotional organisation.
People who did not have a large heart rate response to a stress task surprised researchers later - after the onset of the COVID-19 pandemic - when they showed more symptoms of post-traumatic stress disorder related to the crisis than others who also did the stress task and COVID-19 stress ratings.
GAIN - the Global Alliance for Improved Nutrition released today its 2008-2009 Annual Report. The report confirms the effectiveness of GAIN's work in reducing malnutrition in high-burden countries.
Researchers at the University of Iowa Carver College of Medicine have discovered a genetic process that can restore function to a defective protein, which is the most common cause of cystic fibrosis (CF).
Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.
› Verified 1 days ago
Dr. Amy Samantha May Paul, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1250 E Marshall St, Dept. Of Internal Medicine/geriatric Medicine, Richmond, VA 23298 Phone: 804-254-3500 Fax: 804-254-1616 | |
Dr. Clifton Linwood Parker, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 8300 Fulham Drive, Richmond, VA 23227 Phone: 804-264-5901 | |
Dr. Michael A Mistretta, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6600 W Broad St Ste 300, Richmond, VA 23230 Phone: 804-320-4243 Fax: 804-622-0552 | |
Patricia J Sime, MD Nephrology Medicare: Medicare Enrolled Practice Location: 9000 Stony Point Pkwy, Richmond, VA 23235 Phone: 804-560-8921 Fax: 804-560-8992 | |
Dr. Katherine Lavan Smallwood, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 6900 Forest Ave, Suite 300, Richmond, VA 23230 Phone: 804-346-1515 Fax: 804-270-2888 | |
Walid G. Abou Assi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 7605 Forest Ave, Suite 109, Richmond, VA 23229 Phone: 804-285-6390 Fax: 804-285-6393 | |
Dr. Paulina Essah, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 719 N 25th St, Richmond, VA 23223 Phone: 804-253-1963 Fax: 804-780-0862 |